Non-Invasive Cancer Diagnostics Market is expanding rapidly with LabCorp launching a non-invasive test ctDx Lung for patients with non-small cell lung cancer

 

There are many different types of non-invasive cancer diagnostics available. These tests include the use of a PAP or nasal passage plethoracic device, mammography, magnetic resonance imaging, or CTV. Each one has its own purpose and some of them may be combined to improve accuracy. Non-invasive cancer diagnostics are witnessing wider adoption across the globe. With non-invasive diagnostics, it is possible to examine tissue in its natural state, which allows continued monitoring of the skin site. Besides, it removes additional steps for medical personnel and minimizes additional agitation. Since cancer cases are rising worldwide, non-invasive diagnostics has increased over the years. As per the World Health Organization (WHO), in 2018, around 9.6 million died due to cancer with over 300,000 new cases of cancer being diagnosed each year among children aged 0-19 years across the globe. Thus, such factors can stimulate growth of the non-invasive cancer diagnostics market.

Since there are high healthcare expenditure and research and development activities in the U.S., the non-invasive cancer diagnostics market is likely to expand rapidly. Besides, rising cases of breast cancer can accelerate the regional market growth in the near future. On the contrary, Asia Pacific is gaining rapid traction in the non-invasive cancer diagnostics market due to rising awareness among people regarding the benefits of minimally invasive equipment.

Recently, in September 2020, Laboratory Corporation of America Holdings launched a non-invasive test ctDx Lung for patients with non-small cell lung cancer.

Mammography is another common diagnostic test. In this test, a tube with light or camera at the end is inserted into the nose and it looks like a tube coming out of the mouth. A machine that makes noises similar to snoring is used to produce images from the inside of the nose. These images are then sent to a lab and a diagnosis is made. This test is used for non-melanoma skin cancer and certain types of bladder cancer. That being said, there are certain challenges that can limit the adoption of non-invasive diagnostics methods. Stringent government regulations remain one of the major hurdles, which can impede growth of the non-invasive cancer diagnostics market.

Non-invasive testing can help save people from serious diseases such as cancer, but it is always important to have them tested by a certified doctor. Over the years, medical professionals have started adopting innovative diagnostics tools to minimize agitation. These novel tools are far more sophisticated and efficient than their predecessors can offer a rapid and accurate diagnoses. People suffering from cancer across the globe are increasingly preferring non-invasive diagnostics operations due to their easy availability and precise results. Hence, such factors can augment growth of the non-invasive cancer diagnostics market.